AFP and Cirrhosis: Siddiqui et al. [29], focusing specifically on patients with early-stage cirrhosis (Child–Pugh A), found a 24.5% prevalence of PVT, emphasizing that even compensated patients with large tumors and elevated alpha-fetoprotein (AFP) levels are at significant thrombotic risk.